Relative effectiveness of primidone (Mysoline) and diphenylhydantoin (Dilantin) in the management of sedative withdrawal seizures.
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D010640:Phenothiazines; D010672:Phenytoin / Q000627:therapeutic use*; D011324:Primidone / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy* / Q000209:etiology; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D014150:Antipsychotic Agents; D010640:Phenothiazines; D011324:Primidone; D010672:Phenytoin; D002707:Chlordiazepoxide